Baxter International Share Price (NYSE: BAX)

$24.53

▲

0.68

(2.85%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Baxter International Stock chart to analyse performance

Baxter International stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$24.10
Today's High:$24.61
$24.53
1.75%
Downside
Day's Volatility :2.05%
Upside
0.3%
52 Weeks Low:$21.33
52 Weeks High:$40.49
$24.53
13.05%
Downside
52 Weeks Volatility :47.32%
Upside
39.42%

Baxter International Stock Returns

Period	Baxter International Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-20.55%	6.0%	0.0%
6 Months	-30.09%	-5.6%	0.0%
1 Year	-34.67%	-11.1%	0.0%
3 Years	-58.23%	6.8%	-7.8%

Baxter International Inc. Key Stats

Check Baxter International key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$23.85
Open	$24.22
Today's High	$24.605
Today's Low	$24.1
Market Capitalization	$12.2B
Today's Volume	$6.5M
52 Week High	$40.49
52 Week Low	$21.33
Revenue TTM	$10.9B
EBITDA	$2.0B
Earnings Per Share (EPS)	$-0.48
Dividend Yield	3.3%
Profit Margin	-1.42%
Quarterly Earnings Growth YOY	2.38%
Return On Equity TTM	-3.21%

Stock Returns calculator for Baxter International Stock including INR - Dollar returns

The Baxter International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Baxter International investment value today

Current value as on today

₹69,659

Returns

₹30,341

(-30.34%)

Returns from Baxter International Stock

₹34,656 (-34.66%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Baxter International Stock

230.0%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Investment in Baxter International Shares from India has grown by 230.0% over the past 30 days, indicating increased transactional activity.

70%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Baxter International Stock from India on INDmoney has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Baxter International Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	4148	-11.82	0.02%

Global Institutional Holdings in Baxter International Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
13.03%
Vanguard Group Inc
12.11%
Dodge & Cox
10.15%
Pzena Investment Management, LLC
7.16%
T. Rowe Price Associates, Inc.
4.28%
State Street Corp
4.24%

Analyst Recommendation on Baxter International Stock

Rating

Trend

Hold

35%Buy

65%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Baxter International(by analysts ranked 0 to 5 stars)

Baxter International Share Price Target

What analysts predicted

Upside of 19.68%

Target:

$29.36

Current:

$24.53

Baxter International share price target is $29.36, a slight Upside of 19.68% compared to current price of $24.53 as per analysts' prediction.

Baxter International Stock Insights

Price Movement
In the last 1 month, BAX stock has moved down by -14.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.62B → 2.81B (in $), with an average increase of 6.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 126.0M → 91.0M (in $), with an average decrease of 27.8% per quarter
BAX vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 29.6% return, outperforming this stock by 64.3%
BAX vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 30.7% return, outperforming this stock by 88.9%
Price to Sales
ForBAX every $1 of sales, investors are willing to pay $1.2, whereas for Resmed Inc., the investors are paying $8.4 for every $1 of sales.

Baxter International Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$11.4B	↑ 2.37%
Net Income	$1.0B	↓ 35.25%
Net Profit Margin	8.81%	↓ 5.12%

	FY20	Y/Y Change
Revenue	$11.7B	↑ 2.74%
Net Income	$1.1B	↑ 10.09%
Net Profit Margin	9.44%	↑ 0.63%

	FY21	Y/Y Change
Revenue	$12.1B	↑ 4.05%
Net Income	$1.3B	↑ 16.52%
Net Profit Margin	10.57%	↑ 1.13%

	FY22	Y/Y Change
Revenue	$10.1B	↓ 17.2%
Net Income	$-2.4B	↓ 289.49%
Net Profit Margin	-24.19%	↓ 34.76%

	FY23	Y/Y Change
Revenue	$10.4B	↑ 3.01%
Net Income	$2.7B	↓ 209.17%
Net Profit Margin	25.64%	↑ 49.83%

	FY24	Y/Y Change
Revenue	$10.6B	↑ 2.66%
Net Income	$-649.0M	↓ 124.44%
Net Profit Margin	-6.1%	↓ 31.74%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.5B	↓ 35.91%
Net Income	$37.0M	↓ 84.9%
Net Profit Margin	1.49%	↓ 4.82%

	Q2 FY24	Q/Q Change
Revenue	$3.8B	↑ 53.09%
Net Income	$-314.0M	↓ 948.65%
Net Profit Margin	-8.24%	↓ 9.73%

	Q3 FY24	Q/Q Change
Revenue	$2.7B	↓ 29.2%
Net Income	$140.0M	↓ 144.59%
Net Profit Margin	5.19%	↑ 13.43%

	Q4 FY24	Q/Q Change
Revenue	$2.8B	↑ 2.0%
Net Income	$-512.0M	↓ 465.71%
Net Profit Margin	-18.6%	↓ 23.79%

	Q1 FY25	Q/Q Change
Revenue	$2.6B	↓ 4.65%
Net Income	$126.0M	↓ 124.61%
Net Profit Margin	4.8%	↑ 23.4%

	Q2 FY25	Q/Q Change
Revenue	$2.8B	↑ 7.05%
Net Income	$91.0M	↓ 27.78%
Net Profit Margin	3.24%	↓ 1.56%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$4.8B	↑ 0.04%

	FY20	Y/Y Change
Profit	$4.6B	↓ 3.65%

	FY21	Y/Y Change
Profit	$4.7B	↑ 2.9%

	FY22	Y/Y Change
Profit	$3.5B	↓ 24.81%

	FY23	Y/Y Change
Profit	$4.2B	↑ 16.93%

	FY24	Y/Y Change
Profit	$4.0B	↓ 4.0%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$961.0M	↓ 34.71%

	Q2 FY24	Q/Q Change
Profit	$1.4B	↑ 48.91%

	Q3 FY24	Q/Q Change
Profit	$1.0B	↓ 27.81%

	Q4 FY24	Q/Q Change
Profit	$959.0M	↓ 7.16%

	Q1 FY25	Q/Q Change
Profit	$861.0M	↓ 10.22%

	Q2 FY25	Q/Q Change
Profit	$1.1B	↑ 31.36%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$2.1B	↑ 4.31%
Investing Cash Flow	$-1.1B	↑ 20.09%
Financing Cash Flow	$498.0M	↓ 119.13%

	FY20	Y/Y Change
Operating Cash Flow	$1.9B	↓ 11.22%
Investing Cash Flow	$-1.2B	↑ 7.18%
Financing Cash Flow	$-345.0M	↓ 169.28%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 18.95%
Investing Cash Flow	$-11.2B	↑ 849.96%
Financing Cash Flow	$8.2B	↓ 2489.86%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 45.5%
Investing Cash Flow	$-931.0M	↓ 91.69%
Financing Cash Flow	$-1.4B	↓ 117.44%

	FY23	Y/Y Change
Operating Cash Flow	$1.7B	↑ 42.53%
Investing Cash Flow	$3.2B	↓ 445.11%
Financing Cash Flow	$-3.5B	↑ 142.63%

	FY24	Y/Y Change
Operating Cash Flow	$1.0B	↓ 40.96%
Investing Cash Flow	$-626.0M	↓ 119.48%
Financing Cash Flow	$-1.1B	↓ 69.02%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$163.0M	↓ 69.3%
Investing Cash Flow	$-166.0M	↓ 27.83%
Financing Cash Flow	$-140.0M	↓ 95.23%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$115.0M	↓ 29.45%
Investing Cash Flow	$-91.0M	↓ 45.18%
Financing Cash Flow	$-936.0M	↑ 568.57%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$253.0M	↑ 120.0%
Investing Cash Flow	$-164.0M	↑ 80.22%
Financing Cash Flow	$-146.0M	↓ 84.4%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$488.0M	↑ 92.89%
Investing Cash Flow	$-205.0M	↑ 25.0%
Financing Cash Flow	$141.0M	↓ 196.58%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-193.0M	↓ 139.55%
Investing Cash Flow	$3.3B	↓ 1692.68%
Financing Cash Flow	$-3.2B	↓ 2387.94%

Baxter International Technicals Summary

Sell

Neutral

Buy

Baxter International is currently in a neutral trading position according to technical analysis indicators.

Baxter International Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Baxter International Inc.	-14.75%	-30.09%	-34.67%	-58.23%	-70.75%
Intuitive Surgical, Inc.	-2.56%	-19.44%	-2.15%	115.95%	105.29%
Alcon Ag	-10.73%	-8.13%	-14.62%	18.33%	39.45%
West Pharmaceutical Services Inc	-11.26%	12.04%	-18.2%	-20.25%	-8.15%
Resmed Inc.	7.37%	27.87%	29.57%	31.26%	66.46%
Becton, Dickinson And Company	8.77%	-13.27%	-15.5%	-22.69%	-21.66%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Baxter International Inc.	87.85	NA	2.0	2.45	-0.03	0.03	0.03	14.26
Intuitive Surgical, Inc.	65.35	65.35	3.52	8.12	0.16	0.09	NA	49.79
Alcon Ag	36.66	36.66	2.16	3.09	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.38	36.38	3.56	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	30.29	30.29	1.95	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.88	35.88	1.0	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Baxter International Inc.	Hold	$12.2B	-70.75%	87.85	-1.42%
Intuitive Surgical, Inc.	Buy	$168.4B	105.29%	65.35	28.51%
Alcon Ag	Buy	$39.3B	39.45%	36.66	10.7%
West Pharmaceutical Services Inc	Buy	$17.4B	-8.15%	36.38	16.48%
Resmed Inc.	Buy	$42.2B	66.46%	30.29	27.22%
Becton, Dickinson And Company	Buy	$56.4B	-21.66%	35.88	7.41%

Baxter International Dividend announcements

Baxter International Dividends September, 2025
In the quarter ending September,2025. Baxter International has declared dividend of $0.17

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Organization	Baxter International
Employees	38000
CEO	Mr. David Brent Shafer
Industry	Health Technology

Key Management of Baxter International Inc.

Name	Title
Mr. David Brent Shafer	Chair & Interim CEO
Mr. Joel T. Grade	Executive VP & CFO
Ms. Heather Knight	Executive Vice President & COO
Mr. Jose E. Almeida	Advisor
Mr. Alok Sonig B.E., Mba	Executive VP & Group President of Pharmaceuticals
Ms. Anita A. Zielinski	Senior VP, Chief Accounting Officer & Controller
Ms. Tobi Karchmer M.D., M.S.	Senior VP and Chief Medical & Scientific Officer
Mr. Charles Rusty Patel	Senior VP & Chief Information Officer
Ms. Clare Trachtman	Vice President of Investor Relations
Mr. David S. Rosenbloom	Executive VP & General Counsel

Important FAQs about investing in BAX Stock from India :

What is Baxter International share price today?

Baxter International share price today is $24.53 as on August 23, 2025 at 1:29 AM IST at the close of the market. Baxter International share today touched a day high of $24.61 and a low of $24.10.

What is the 52 week high and 52 week low for Baxter International share?

Baxter International share touched a 52 week high of $40.49 and a 52 week low of $21.33. Baxter International stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $24.53, lower by 39.42% versus the 52 week high.

How to invest in Baxter International Stock (BAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Baxter International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Baxter International Shares that will get you 0.0611 shares as per Baxter International share price of $24.53 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Baxter International Stock (BAX) from India?

Indian investors can start investing in Baxter International (BAX) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Baxter International stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Baxter International share’s latest price of $24.53 as on August 23, 2025 at 1:29 AM IST, you will get 0.4077 shares of Baxter International. Learn more about fractional shares .

What are the returns that Baxter International has given to Indian investors in the last 5 years?

Baxter International stock has given -70.75% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?